Shares of BrainsWay Ltd. (BWAY) hit an all-time high of $16.99 yesterday, and that reflects a gain of nearly 79% year-to-date.
The company's flagship technology is Deep Transcranial Magnetic Stimulation or Deep TMS. The approved indications for Deep TMS include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction, with additional indications in various psychiatric, neurological, and addiction disorders being explored.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.